• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的质子治疗方案在小儿肿瘤患者全肺照射中与光子治疗相比,能提供更好的心脏保护。

A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients.

作者信息

Sha Xue, Duan Jinghao, Lin Xiutong, Zhu Jian, Zhang Ruohui, Sun Tao, Wang Hui, Meng Xiangjuan, Yin Yong

机构信息

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Shandong Provincial Key Laboratory of Digital Medicine and Computer-Assisted Surgery, Qingdao, China.

出版信息

Front Oncol. 2021 Feb 2;10:611514. doi: 10.3389/fonc.2020.611514. eCollection 2020.

DOI:10.3389/fonc.2020.611514
PMID:33604292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884855/
Abstract

OBJECTIVE

Whole lung irradiation (WLI) plays a crucial role in local control in pediatric patients with lung metastases and improves patient survival. The intention of this research was to explore the advantage of cardiac sparing between photons and protons during WLI. We also propose a new solution for cardiac sparing with proton techniques.

METHODS

Eleven patients with pediatric tumors and pulmonary metastasis treated with 12 Gy WLI (all received volumetric-modulated arc therapy (VMAT)) in our institute between 2010 and 2019 were retrospectively selected. Each patient was replanned with intensity-modulated radiation therapy (IMRT), helical tomotherapy (HT), and two intensity-modulated proton radiotherapy (IMPT) plans (IMPT-1 and IMPT-2). IMPT-1 considered the whole lung as the planning target volume (PTV), utilizing the anteroposterior technique (0/180°). IMPT-2 was a new proton solution that we proposed in this research. This approach considered the unilateral lung as the PTV, and 3 ipsilateral fields were designed for each lung. Then, IMPT-2 was generated by summing two unilateral lung plans. The primary objective was to obtain adequate coverage (95% of the prescription dose to the PTV) while maximally sparing the dose to the heart. The PTV coverage, conformity index (CI), homogeneity index (HI), and dose-volume statistics of the heart and substructures were assessed by means of the averages of each comparison parameter.

RESULTS

All treatment techniques achieved the target volume coverage required by clinical practice. HT yielded the best coverage and homogeneity for the target structure compared with other techniques. The CI from IMRT was excellent. For photon radiation therapy, the HT plan afforded superior dose sparing for the V, V, V, V, and D of the heart and D of the right ventricle (RV). IMRT displayed the most notable dose reductions in the V, V, V, and V of the heart and D of the right atrium (RA). The VMAT plan was the least effective on the heart and substructures. However, compared with photon radiation therapy, IMPT-1 did not show an advantage for heart protection. Interestingly, IMPT-2 provided significant superiority in cardiac sparing, including maximum dose sparing for the V, V, V, V, V and D of the heart and D of the RA, RV, left atrium (LA) and left ventricle (LV) compared to all other techniques.

CONCLUSIONS

Considering the complex anatomical relation between target volumes and organs at risk (OARs), IMPT can provide a dose advantage for organs located outside of the target area rather than within or surrounding the area. It is hoped that advances in proton therapy (PT) plan design will lead to further improvements in radiotherapy approaches and provide the best treatment choice for individual patients.

摘要

目的

全肺照射(WLI)在小儿肺转移瘤患者的局部控制中起着关键作用,并能提高患者生存率。本研究旨在探讨WLI期间光子和质子在心脏保护方面的优势。我们还提出了一种利用质子技术进行心脏保护的新方案。

方法

回顾性选取2010年至2019年在我院接受12 Gy WLI治疗(均接受容积调强弧形放疗(VMAT))的11例小儿肿瘤伴肺转移患者。对每位患者分别采用调强放射治疗(IMRT)、螺旋断层放疗(HT)以及两种调强质子放疗(IMPT)计划(IMPT-1和IMPT-2)进行重新计划。IMPT-1将全肺作为计划靶区(PTV),采用前后向技术(0/180°)。IMPT-2是我们在本研究中提出的一种新的质子方案。该方法将单侧肺作为PTV,为每侧肺设计3个同侧野。然后,通过将两个单侧肺计划相加生成IMPT-2。主要目的是在最大程度减少心脏受量的同时获得足够的靶区覆盖(PTV接受95%的处方剂量)。通过各比较参数的平均值评估PTV覆盖情况、适形指数(CI)、均匀性指数(HI)以及心脏和亚结构的剂量体积统计数据。

结果

所有治疗技术均达到了临床实践要求的靶区覆盖。与其他技术相比,HT对靶区结构的覆盖和均匀性最佳。IMRT的CI极佳。对于光子放射治疗,HT计划在心脏的V、V、V、V以及右心室(RV)的D和右心房(RA)的D方面提供了更好的剂量 sparing。IMRT在心脏的V、V、V、V以及右心房的D方面显示出最显著的剂量降低。VMAT计划对心脏和亚结构的效果最差。然而,与光子放射治疗相比,IMPT-1在心脏保护方面未显示出优势。有趣的是,与所有其他技术相比,IMPT-2在心脏保护方面具有显著优势,包括在心脏的V、V、V、V、V以及RA、RV、左心房(LA)和左心室(LV)的D方面实现了最大剂量 sparing。

结论

考虑到靶区与危及器官(OARs)之间复杂的解剖关系,IMPT可为位于靶区外而非靶区内或靶区周围的器官提供剂量优势。希望质子治疗(PT)计划设计的进展将进一步改善放射治疗方法,并为个体患者提供最佳治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/5f7449640568/fonc-10-611514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/822361b90ab0/fonc-10-611514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/49298e65ef43/fonc-10-611514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/5f7449640568/fonc-10-611514-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/822361b90ab0/fonc-10-611514-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/49298e65ef43/fonc-10-611514-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2de/7884855/5f7449640568/fonc-10-611514-g003.jpg

相似文献

1
A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients.一种新的质子治疗方案在小儿肿瘤患者全肺照射中与光子治疗相比,能提供更好的心脏保护。
Front Oncol. 2021 Feb 2;10:611514. doi: 10.3389/fonc.2020.611514. eCollection 2020.
2
Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.同步双侧乳腺放疗中心脏及心脏亚结构的剂量 sparing:质子和光子放射治疗的剂量学研究
Front Oncol. 2020 Jan 10;9:1456. doi: 10.3389/fonc.2019.01456. eCollection 2019.
3
Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.哪种放疗技术对局部晚期宫颈癌患者最有益?调强质子治疗与调强光子治疗、螺旋断层放疗和容积弧形调强放疗用于初次放疗的个体内比较。
Radiat Oncol. 2015 Apr 17;10:91. doi: 10.1186/s13014-015-0402-z.
4
Cardiac-Sparing and Breast-Sparing Whole Lung Irradiation Using Intensity-Modulated Proton Therapy.使用调强质子治疗的心脏保护和乳腺保护全肺照射
Int J Part Ther. 2021 Mar 9;7(4):65-73. doi: 10.14338/IJPT-20-00079.1. eCollection 2021 Spring.
5
Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy.光子与质子在后乳腺癌根治术后超分割放疗计划中的剂量学评估。
Radiat Oncol. 2022 Jan 29;17(1):20. doi: 10.1186/s13014-022-01992-w.
6
Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.容积调强弧形放疗与调强质子放疗在局部晚期食管癌新辅助放疗中的应用比较
Radiat Oncol. 2020 May 24;15(1):120. doi: 10.1186/s13014-020-01570-y.
7
Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.基于 CT、FDG-PET、DTI-MRI 和纤维追踪的恶性胶质瘤的光子和质子治疗计划比较。
Acta Oncol. 2011 Aug;50(6):777-83. doi: 10.3109/0284186X.2011.584555.
8
Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma.食管鳞状细胞癌全靶区质子放疗与光子放疗的剂量学分析及生物学评价
Front Oncol. 2022 Oct 3;12:954187. doi: 10.3389/fonc.2022.954187. eCollection 2022.
9
Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer.针对食管癌患者的不同功能性肺保护策略及放射治疗技术。
Front Oncol. 2022 Aug 26;12:898141. doi: 10.3389/fonc.2022.898141. eCollection 2022.
10
Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.TomoDirect、螺旋断层放疗、容积调强弧形放疗和固定野调强适形放疗在上段食管癌治疗中的剂量学比较
Med Dosim. 2019;44(2):167-172. doi: 10.1016/j.meddos.2018.05.001. Epub 2018 Jun 24.

引用本文的文献

1
The Thoracic Absorption Dose and Secondary Tumor Risk Caused by Different Imaging Methods in Image-Guided Particle Radiotherapy.图像引导粒子放射治疗中不同成像方法所致的胸部吸收剂量及继发肿瘤风险
Thorac Cancer. 2025 Jun;16(12):e70102. doi: 10.1111/1759-7714.70102.
2
Feasibility of Utilizing Spot-Scanning Proton Arc (SPArc) for Whole-Lung Irradiation: A Case Report.利用点扫描质子弧形放疗(SPArc)进行全肺照射的可行性:一例报告
Int J Part Ther. 2025 May 22;16:100750. doi: 10.1016/j.ijpt.2025.100750. eCollection 2025 Jun.
3
Narrative Review: Cardiotoxicities and Cardiac-Sparing Techniques in Radiotherapy.

本文引用的文献

1
The role of proton therapy in pediatric malignancies: Recent advances and future directions.质子治疗在儿科恶性肿瘤中的作用:最新进展和未来方向。
Semin Oncol. 2020 Feb;47(1):8-22. doi: 10.1053/j.seminoncol.2020.02.002. Epub 2020 Feb 21.
2
Role of Metastatic Site Irradiation in Pediatric Patients With Metastatic Ewing Sarcoma.转移性骨尤文肉瘤患儿转移灶放疗的作用。
J Pediatr Hematol Oncol. 2020 Jul;42(5):e305-e309. doi: 10.1097/MPH.0000000000001752.
3
Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.
叙述性综述:放射治疗中的心脏毒性和心脏保护技术
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241301211. doi: 10.1177/15330338241301211.
4
Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma.食管鳞状细胞癌全靶区质子放疗与光子放疗的剂量学分析及生物学评价
Front Oncol. 2022 Oct 3;12:954187. doi: 10.3389/fonc.2022.954187. eCollection 2022.
基于颅内肿瘤位置的质子放射治疗、容积调强弧形放疗和三维适形放疗的剂量学比较
Cancers (Basel). 2018 Oct 26;10(11):401. doi: 10.3390/cancers10110401.
4
Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.儿童肿瘤和肺转移患者的心脏保护全肺调强放疗:前瞻性多中心临床试验的最终报告。
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):28-37. doi: 10.1016/j.ijrobp.2018.08.034. Epub 2018 Aug 29.
5
Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.质子治疗儿科恶性肿瘤:事实、数据和成本。来自 PTCOG、PROS 和 EPTN 的儿科小组委员会的联合共识声明。
Radiother Oncol. 2018 Jul;128(1):44-55. doi: 10.1016/j.radonc.2018.05.020. Epub 2018 Jun 21.
6
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.儿童癌症幸存者的心血管疾病:流行病学、病理生理学和预防的见解。
J Clin Oncol. 2018 Jul 20;36(21):2135-2144. doi: 10.1200/JCO.2017.76.3920. Epub 2018 Jun 6.
7
International incidence of childhood cancer, 2001-10: a population-based registry study.国际儿童癌症发病率,2001-2010 年:基于人群的注册研究。
Lancet Oncol. 2017 Jun;18(6):719-731. doi: 10.1016/S1470-2045(17)30186-9. Epub 2017 Apr 11.
8
Promise and pitfalls of heavy-particle therapy.重粒子治疗的前景与挑战。
J Clin Oncol. 2014 Sep 10;32(26):2855-63. doi: 10.1200/JCO.2014.55.1945. Epub 2014 Aug 11.
9
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
10
Cardiac-sparing whole lung IMRT in children with lung metastasis.儿童肺部转移瘤的心脏保护全肺调强放疗。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):761-7. doi: 10.1016/j.ijrobp.2012.05.036. Epub 2012 Jul 18.